Effect of lomeguatrib–temozolomide combination on MGMT promoter methylation and expression in primary glioblastoma tumor cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effect of lomeguatrib–temozolomide combination on MGMT promoter methylation and expression in primary glioblastoma tumor cells

Published:2013-03-22 Issue:3 Volume:34 Page:1935-1947
ISSN:1010-4283
Container-title:Tumor Biology
language:en
Short-container-title:Tumor Biol.

Author:

Taspinar Mehmet,Ilgaz Seda,Ozdemir Mevci,Ozkan Tulin,Oztuna Derya,Canpinar Hande,Rey Juan A.,Sunguroğlu Asuman,Castresana Javier S.,Ugur Hasan Caglar

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13277-013-0738-7.pdf

Reference57 articles.

1. Rosell R, De Las PR, Balana C, Santarpia M, Salazar F, de Aguirre I, et al. Translational research in glioblastoma multiforme: molecular criteria for patient selection. Future Oncol. 2008;4:219–28.

2. Iacob G, Dinca EB. Current data and strategy in glioblastoma multiforme. J Med Life. 2009;2:386–93.

3. Krakstad C, Chekenya M. Survival signaling and apoptosis resistance in glioblastoma: oppurtunities for targeted therapeutics. Mol Cancer. 2010;9:135.

4. Adamson C, Kanu OO, Mehta AI, Di C, Lin N, Mattox AA, et al. Glioblastoma multiforme: a review of where we have been and where we are going. Expert Opin Investig Drugs. 2009;18:1061–83.

5. Omay SB, Vogelbaum MA. Current concepts and newer developments in the treatment of malignant gliomas. Indian J Cancer. 2009;46:88–95.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MGMT inhibition regulates radioresponse in GBM, GSC, and melanoma;Scientific Reports;2024-05-29

2. Dual-targeted delivery of temozolomide by multi-responsive nanoplatform via tumor microenvironment modulation for overcoming drug resistance to treat glioblastoma;Journal of Nanobiotechnology;2024-05-17

3. Inhibition of O6‐methylguanine‐DNA‐methyltransferase (MGMT) by lomeguatrib reduces multiple myeloma cell viability and impairs DNA repair in MGMT‐proficient cells;Chemical Biology & Drug Design;2024-01-29

4. A hypoxia-dissociable siRNA nanoplatform for synergistically enhanced chemo-radiotherapy of glioblastoma;Biomaterials Science;2022

5. Lomeguatrib Increases the Radiosensitivity of MGMT Unmethylated Human Glioblastoma Multiforme Cell Lines;International Journal of Molecular Sciences;2021-06-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3